These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38298268)

  • 41. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
    Strowski MZ; Parmar RM; Blake AD; Schaeffer JM
    Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of islet hormones on insulin secretion from cloned B cell lines, HIT-T15 and RINm5F.
    Lambert DG; Atkins TW
    J Endocrinol; 1989 Jun; 121(3):479-85. PubMed ID: 2569024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of somatostatin receptor type 2 antagonism during insulin-induced hypoglycaemia in male rats with prediabetes.
    Hoffman EG; D'Souza NC; Aiken J; Atherley S; Liggins R; Riddell MC
    Diabetes Obes Metab; 2023 Jun; 25(6):1547-1556. PubMed ID: 36734462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus.
    Meyer C; Hering BJ; Grossmann R; Brandhorst H; Brandhorst D; Gerich J; Federlin K; Bretzel RG
    Transplantation; 1998 Jul; 66(2):233-40. PubMed ID: 9701271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of glucagon, catecholamines and cortisol in counterregulation of insulin-induced hypoglycemia in normal man.
    Lins PE; Adamson U; Clausen N; Hamberger B; Efendić S
    Acta Med Scand; 1986; 220(1):39-46. PubMed ID: 2876589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes.
    Leclair E; Liggins RT; Peckett AJ; Teich T; Coy DH; Vranic M; Riddell MC
    Diabetologia; 2016 Aug; 59(8):1724-31. PubMed ID: 27075449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatostatin Containing δ-Cell Number Is Reduced in Type-2 Diabetes.
    Kothegala L; Miranda C; Singh M; Krieger JP; Gandasi NR
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P/Q-type Ca
    Ramracheya R; Chapman C; Chibalina M; Dou H; Miranda C; González A; Moritoh Y; Shigeto M; Zhang Q; Braun M; Clark A; Johnson PR; Rorsman P; Briant LJB
    Physiol Rep; 2018 Sep; 6(17):e13852. PubMed ID: 30187652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paracrine regulation of glucagon secretion: the β/α/δ model.
    Watts M; Ha J; Kimchi O; Sherman A
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E597-E611. PubMed ID: 26837808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pancreatic network control of glucagon secretion and counterregulation.
    Farhy LS; McCall AL
    Methods Enzymol; 2009; 467():547-581. PubMed ID: 19897107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon.
    Collins SC; Salehi A; Eliasson L; Olofsson CS; Rorsman P
    Diabetologia; 2008 Sep; 51(9):1689-93. PubMed ID: 18622593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Catecholamine responses and their interactions with other glucoregulatory hormones.
    Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets.
    Wang F; Adrian TE; Westermark GT; Ding X; Gasslander T; Permert J
    Am J Physiol; 1999 Jan; 276(1):E19-24. PubMed ID: 9886946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lilly lecture 1988. Glucose counterregulation and its impact on diabetes mellitus.
    Gerich JE
    Diabetes; 1988 Dec; 37(12):1608-17. PubMed ID: 3056759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Restoring glutamate receptor signaling in pancreatic alpha cells rescues glucagon responses in type 1 diabetes.
    Panzer JK; Tamayo A; Caicedo A
    Cell Rep; 2022 Dec; 41(11):111792. PubMed ID: 36516761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurotransmitter control of islet hormone pulsatility.
    Gylfe E; Tengholm A
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():102-10. PubMed ID: 25200303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatostatin receptors in congenital hyperinsulinism: Biology to bedside.
    van Albada ME; Mohnike K; Dunne MJ; Banerjee I; Betz SF
    Front Endocrinol (Lausanne); 2022; 13():921357. PubMed ID: 36237195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Importance of multiple endocrine cell types in islet organoids for type 1 diabetes treatment.
    Heaton ES; Jin S
    Transl Res; 2022 Dec; 250():68-83. PubMed ID: 35772687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes mellitus secondary to chronic pancreatitis.
    Larsen S
    Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.